Published in J Neurol Neurosurg Psychiatry on September 01, 1982
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
CT ring sign imitating tumour, disclosed as multiple sclerosis by MRI: a case report. J Neurol Neurosurg Psychiatry (1989) 1.08
Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry (1991) 0.96
Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psychiatry (1993) 0.81
Cerebral CT lesions in multiple sclerosis mimicking multiple metastases. J Neurol Neurosurg Psychiatry (1991) 0.75
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms. AJR Am J Roentgenol (2015) 0.75
CT scans suggestive of tumour in multiple sclerosis. J Neurol Neurosurg Psychiatry (1983) 0.75
The EMI scanner. A brief review of the first 650 patients. Br J Radiol (1974) 3.66
Cranial CT in multiple sclerosis showing a mass effect. Surg Neurol (1979) 1.70
Epilepsy and disseminated sclerosis. Q J Med (1962) 1.46
Computer assisted tomography of the head. An early evaluation. Mayo Clin Proc (1974) 1.30
Computerized tomography of brain and optic nerve in multiple sclerosis. Observations in 100 patients, including serial studies in 16. J Neurol Sci (1978) 1.19
Computerized tomography of the brain. Radiol Clin North Am (1974) 1.18
Active multiple sclerosis. Enhanced computerized tomographic imaging of lesions and the effect of corticosteroids. Arch Neurol (1978) 1.17
Iodide and xenon enhancement of computed tomography (CT) in multiple sclerosis (MS). Neuroradiology (1978) 1.11
Computer tomography of the cerebrum in multiple sclerosis. Neuroradiology (1976) 1.06
Computer tomography of the brain in multiple sclerosis. A radiological study of 110 patients with special reference to demonstration of cerebral plaques. Acta Neurol Scand (1976) 1.04
Multiple sclerosis presenting with acute remitting psychiatric symptoms. J Neurol Neurosurg Psychiatry (1979) 1.04
Some limitations of computed tomography in the diagnosis of neurological diseases. AJR Am J Roentgenol (1976) 1.02
Cerebral multiple sclerosis. Neurology (1971) 0.98
Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan. Ann Neurol (1979) 0.97
Computerised axial tomography in multiple sclerosis. Lancet (1976) 0.95
Cranial CT appearance of acute multiple sclerosis. Neurology (1978) 0.92
Computerized cranial tomography in cerebral diseases of white matter. Neurology (1978) 0.91
Acute multiple sclerosis with contrast-enhancing plaques. Arch Neurol (1978) 0.90
Expanded high iodine dose in computed cranial tomography: a preliminary report. Radiology (1979) 0.89
Computer tomography in disseminated sclerosis. Can J Neurol Sci (1976) 0.89
Plaque of multiple sclerosis seen on computerized transaxial tomogram. Neurology (1977) 0.88
Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann Neurol (1979) 0.86
Contrast-enhanced lesions on computerised tomography in multiple sclerosis. J Neurol Neurosurg Psychiatry (1978) 0.86
Interval computed tomography in multiple sclerosis. Radiology (1978) 0.84
Primary demyelinating disease simulating glioma of the corpus callosum: report of three cases. J Neurosurg (1981) 0.83
CT detection of demyelinated plaques in multiple sclerosis. AJR Am J Roentgenol (1979) 0.82
CT and EEG investigations in 100 patients with multiple sclerosis (MS). Ital J Neurol Sci (1981) 0.81
Computed tomography in the diagnosis of degenerative diseases of the brain. Semin Roentgenol (1977) 0.80
Cervical computed tomography in multiple sclerosis with spinal cord involvement. J Comput Assist Tomogr (1979) 0.80
[Use of cerebral computer tomography for the diagnosis of multiple sclerosis]. Rev Neurol (Paris) (1979) 0.80
Computerized tomography in patients with multiple sclerosis. Clin Neurol Neurosurg (1977) 0.79
Multiple sclerosis and serial computerized tomography. Delayed contrast enhancement of acute and early lesions. Arch Neurol (1980) 0.79
Cranial computerized tomography and chronic multiple sclerosis. Nebr Med J (1978) 0.79
Computed tomography: regression of periventricular enhancing lesions in multiple sclerosis. Comput Tomogr (1979) 0.79
Computerised tomography findings in multiple sclerosis and Schilder's disease. Clin Exp Neurol (1977) 0.78
Case report. Multiple sclerosis: large plaque causing mass effect and ring sign. J Comput Assist Tomogr (1981) 0.78
Detection of demyelinated plaques with xenon-enhanced computed tomography. Neuroradiology (1980) 0.78
Computerized tomography in demyelinating disease of the young. Neurology (1977) 0.78
Electrophysiological and computerised tomography findings in multiple sclerosis: a comparative study. Clin Exp Neurol (1977) 0.78
[Computed tomography in multiple sclerosis]. Rev Neurol (Paris) (1980) 0.78
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33
A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet (2005) 6.14
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet (2004) 5.93
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet (2003) 5.90
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1989) 4.39
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18
Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke (1997) 4.07
Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet (1999) 3.97
Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry (1990) 3.96
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet (1997) 3.76
Very early risk of stroke after a first transient ischemic attack. Stroke (2003) 3.26
Symptomatic carotid ischaemic events: safest and most cost effective way of selecting patients for angiography, before carotid endarterectomy. BMJ (1990) 3.20
A role for medical angiologists? BMJ (1993) 3.18
Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet (2000) 3.07
Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet (1999) 3.05
Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med J (Clin Res Ed) (1987) 2.96
Incidence of transient ischemic attacks in Oxfordshire, England. Stroke (1989) 2.94
Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J (Clin Res Ed) (1985) 2.85
Effect of correcting outcome data for case mix: an example from stroke medicine. BMJ (1996) 2.79
Ethical review of a multicentre study in Scotland: a weighty problem. J R Coll Physicians Lond (2000) 2.77
How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychiatry (2000) 2.72
Cerebral angiographic risk in mild cerebrovascular disease. Stroke (1990) 2.65
Physiotherapy intervention late after stroke and mobility. BMJ (1992) 2.57
Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke (1993) 2.44
CSF opening pressure: reference interval and the effect of body mass index. Neurology (2006) 2.39
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27
The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain (1990) 2.26
Thrombolysis in acute ischemic stroke: does it work? Stroke (1992) 2.23
Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke (2004) 2.22
Complications after acute stroke. Stroke (1996) 2.21
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology (2011) 2.15
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain (1991) 2.15
Local versus general anaesthesia in carotid endarterectomy: a systematic review of the evidence. Eur J Vasc Endovasc Surg (1997) 2.13
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Carotid endarterectomy and the measurement of stenosis. Stroke (1993) 2.10
Levodopa in pregnancy. Mov Disord (1995) 2.06
Detection of bilateral isodense subdural haematomas. BMJ (1994) 2.03
Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci (1982) 2.02
Does the angiographic appearance of a carotid stenosis predict the risk of stroke independently of the degree of stenosis? Clin Radiol (1995) 2.02
Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ (1997) 1.97
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
Differentiating between audit and research. Undue protection of patient confidentiality jeopardises both research and audit. BMJ (2000) 1.93
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2003) 1.78
Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Br J Radiol (1974) 1.77
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76
The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry (1991) 1.73
Comparing stroke incidence worldwide: what makes studies comparable? Stroke (1996) 1.72
The cortex of the primary auditory area in Alzheimer's disease. Brain Res (1986) 1.71
The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70
Amount of research interest in rare and common neurological conditions: bibliometric study. BMJ (2001) 1.68
A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke (1989) 1.67
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain (2004) 1.63
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol (2000) 1.63
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain (2000) 1.62
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol (2000) 1.60
Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J Clin Pathol (1986) 1.60
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain (2001) 1.60
The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol (1993) 1.60
White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke (2001) 1.59
Hospital services for patients with acute stroke in the United Kingdom: the Stroke Association Survey of consultant opinion. Age Ageing (1995) 1.59
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58
5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer (1984) 1.56
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke (1993) 1.54
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci (1983) 1.53
The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52
Variations between countries in outcome after stroke in the International Stroke Trial (IST). Stroke (2001) 1.49
Complications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry (1990) 1.48
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48
Reanalysis of the final results of the European Carotid Surgery Trial. Stroke (2003) 1.47
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47
The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol (2004) 1.46
The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46
Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol (1986) 1.45
Insidious endocarditis caused by Chlamydia psittaci. Br Med J (1975) 1.45
Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke (1990) 1.45
Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke (2000) 1.44
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf) (1989) 1.41
Equivalence of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists' Collaborative Group. Stroke (1994) 1.40
How does the degree of carotid stenosis affect the accuracy and interobserver variability of magnetic resonance angiography? J Neurol Neurosurg Psychiatry (2001) 1.39
Progressive ataxia, focal seizures, and malabsorption syndrome in a 41 year old woman. J Neurol Neurosurg Psychiatry (1996) 1.39
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol (1997) 1.39
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet (1994) 1.38
Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry (1986) 1.37
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer (1974) 1.35